Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0155339 (
Brown
)
12,436
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A rat PAC library was constructed in the vector pPAC4 from genomic DNA isolated from female
Brown
Norway rats. This library consists of 215,409 clones arrayed in 614,384-well microtiter plates. An average insert size of 143 kb was estimated from 217 randomly isolated clones, thus representing approximately 10-fold genome coverage. This coverage provides a very high probability that the library contains a unique sequence in genome screening. Tests on randomly selected clones demonstrated that they are very stable, with only 4 of 130 clones showing restriction digest fragment alterations after 80 generations of serial growth.
FISH
analysis using 70 randomly chosen PACs revealed no significant chimeric clones. About 7% of the clones analyzed contained repetitive sequences related to centromeric regions that hybridized to some but not all centromeres. DNA plate pools and superpools were made, and high-density filters each containing an array of 8 plates in duplicate were prepared. Library screening on these superpools and appropriate filters with 10 single-locus rat markers revealed an average of 8 positive clones, in agreement with the estimated high genomic coverage of this library and representation of the rat genome. This library provides a new resource for rat genome analysis, in particular the identification of genes involved in models of multifactorial disease. The library and high-density filters are currently available to the scientific community.
...
PMID:Construction and characterization of a 10-fold genome equivalent rat P1-derived artificial chromosome library. 967 25
1. ISA
Brown
pullets were transferred from 8 to 14 h or from 14 to 8 h photoperiods at 35 or 56 d of age. Controls were maintained on constant 8 or 14 h photoperiods from day 1. 2. Blood samples were obtained immediately before each daylength change and subsequently at 7 d intervals until 1st egg in the treated groups and at 70 d of age and then at 14 d intervals until 1st egg in the constant photoperiod controls. Plasma luteinising hormone (LH) and follicle stimulating hormone (FSH) concentrations were determined using homologous radioimmunoassays. 3. Prior to 16 weeks, LH was consistently higher in birds on constant 14 h photoperiods than in those on constant 8 h, but was down-regulated as birds approached maturity so that LH concentrations in the 2 groups were similar during the final 10 d before the first egg was laid.
FISH
concentrations rose steadily with age but with a tendency for concentrations to be higher in the 8 h than in the 14 h treatment. Birds on constant 8 h daylengths matured 18.3 d later than those on constant 14 h photoperiods. 4. A 6 h increment in photoperiod given at 35 d or 56 d, resulted in an increase in LH within 7 d in both cases. FSH concentration did not respond to an increase in photoperiod at 35 d but rose following the same increase at 56 d. This was associated with a 3-week advance in sexual maturity, whilst age at 1st egg in birds photostimulated at 35 d was similar to the age with a constant 14 h photoperiod. 5. LH concentration fell when photoperiod was reduced from 14 to 8 h at either 35 or 56 d and remained below the constant 8 h controls for many weeks before rising to a concentration not significantly different from other groups in the final 10 d before 1st egg. FSH concentrations in birds exposed to a decreased daylength at 35 d, although more oscillatory, were similar to the constant 8 h photoperiod controls. In birds exposed to the same decrease at 56 d, FSH concentration initially tumbled but was similar in the 2 groups during the latter stages of rearing; neither differed significantly from the constant daylength controls during the 60 d before 1st egg. Sexual maturity in both groups given a reduction in photoperiod was delayed by about 2 weeks compared with constant 8 h controls. 6. Change in FSH concentration following an increase in daylength was a better predictor of age at 1st egg than change in LH. However, FSH concentrations after 14 weeks of age were rather similar in short day and long day controls and in the 2 groups given reductions in photoperiod at 35 d and 56 d, despite differences of nearly 5 weeks in mean age at 1st egg amongst these 4 treatments.
...
PMID:Effect of constant and of changing photoperiod on plasma LH and FSH concentrations and age at first egg in layer strains of domestic pullets. 992 20
There are many techniques available for the identification of microsporidia in clinical specimens. Chromotrope 2R, calcofluor white M2R and
FISH
technique have all been reported to be useful as selective methods for microsporidia in stool specimens and in body fluids. Microsporidia in histologic tissue preparations have also been visualized with Giemsa, hematoxylin and eosin stain,
Brown
-Hopps stain or Warthin-Starry staining. Microsporidia can also be identified by using tests for detecting IgG and IgM antibodies to Encephalitozoon cuniculi such as the indirect fluorescent antibody (IFA) method and the enzyme-linked immunosorbent assay (ELISA). Transmission electron microscopy (EM) is not readily available. PCR testing of clinical specimens may be helpful in diagnosing the infection. The development of molecular techniques carries the promise of greatly increased diagnostic sensitivity and specificity, as well as provide a tool for use in epidemiological studies.
...
PMID:[Laboratory diagnostics of human microsporidiosis]. 1686 2
Dr Jeanne Lawrence talks to Caroline Telfer, Commissioning Editor. Dr Jeanne Lawrence is an internationally recognized leader in the study of chromosome regulation by noncoding RNA and nuclear and genome organization. Her research bridges fundamental questions about genome regulation with clinical implications of recent advances in epigenetics. Her interest in chromosome structure and regulation has been a theme throughout her career and she has been honored for her work developing sensitive
FISH
technology for the detection of single copy genes, as well as RNAs. Her laboratory's publications include the initial demonstration of cell type-specific gene organization with nuclear subdomains; the novel biology of a noncoding RNA, XIST, which coats a whole X-chromosome to induce its silencing; and a new architectural role for a large noncoding RNA to scaffold a nuclear body. Her laboratory's work on epigenetic chromosome regulation in stem cells led to recent studies regarding unanticipated roles of repeat sequences in normal chromosome regulation and deregulation in cancer. Most recently, her laboratory has demonstrated a new approach to translate the basic mechanism of X-chromosome inactivation to correct a chromosomal dosage imbalance in patient-derived cells with trisomy 21 (Down's syndrome). Dr Lawrence has received awards from numerous agencies, including a Research Career Development Award from the National Center for Human Genome Research, career awards from the American Society of Cell Biology, the German Society for Biochemistry, the Muscular Dystrophy Association and a John Merck Fund Translational Research Award. She has served on the NIH National Advisory Council for Human Genome Research, numerous study sections and is currently a monitoring editor for the Journal of Cell Biology. Dr Lawrence has a BA in Biology and Music from Stephens College (MO, USA), a MS in Human Genetics and Genetic Counseling from Rutgers University (NJ, USA) and a PhD in Developmental Biology from
Brown
University (RI, USA). She is currently a Professor and Interim Chair of the Department of Cell and Developmental Biology at the University of Massachusetts Medical School (MA, USA).
...
PMID:Interview: from Down's syndrome to basic epigenetics and back again. 2428 75